CINECA IRIS Institutional Research Information System

GHIGO, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.268
EU - Europa 4.090
AS - Asia 2.372
SA - Sud America 217
AF - Africa 59
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 5
Totale 13.055
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.166
DK - Danimarca 1.338
CN - Cina 1.243
IT - Italia 862
SG - Singapore 634
IE - Irlanda 350
DE - Germania 334
SE - Svezia 239
BR - Brasile 194
FR - Francia 182
UA - Ucraina 123
FI - Finlandia 122
AT - Austria 105
JP - Giappone 103
GB - Regno Unito 89
CA - Canada 82
BE - Belgio 78
KR - Corea 76
HK - Hong Kong 67
PT - Portogallo 65
IN - India 61
PL - Polonia 61
VN - Vietnam 46
CH - Svizzera 45
AU - Australia 43
NL - Olanda 27
TW - Taiwan 27
ID - Indonesia 24
IR - Iran 22
ES - Italia 18
RU - Federazione Russa 17
SN - Senegal 15
MX - Messico 13
TR - Turchia 13
ET - Etiopia 10
NG - Nigeria 10
NO - Norvegia 9
TH - Thailandia 9
AR - Argentina 7
BD - Bangladesh 7
ZA - Sudafrica 7
CZ - Repubblica Ceca 6
EC - Ecuador 6
IL - Israele 6
EU - Europa 5
PK - Pakistan 5
IQ - Iraq 4
NP - Nepal 4
SI - Slovenia 4
UZ - Uzbekistan 4
EG - Egitto 3
GR - Grecia 3
HU - Ungheria 3
MA - Marocco 3
MO - Macao, regione amministrativa speciale della Cina 3
MY - Malesia 3
RO - Romania 3
UY - Uruguay 3
BW - Botswana 2
BY - Bielorussia 2
BZ - Belize 2
CO - Colombia 2
DO - Repubblica Dominicana 2
GH - Ghana 2
KH - Cambogia 2
KZ - Kazakistan 2
MU - Mauritius 2
PE - Perù 2
UG - Uganda 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
CR - Costa Rica 1
CY - Cipro 1
GP - Guadalupe 1
GT - Guatemala 1
IS - Islanda 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
MK - Macedonia 1
NE - Niger 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
TN - Tunisia 1
ZM - Zambia 1
Totale 13.055
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.594
Chandler 676
Santa Clara 484
Singapore 357
Dublin 349
Beijing 281
Ashburn 280
Torino 255
Houston 244
Shenyang 216
Wilmington 211
Fairfield 159
Turin 139
Nyköping 137
Dearborn 112
Columbus 100
Villeurbanne 93
Vienna 90
Medford 86
Princeton 86
Jacksonville 74
Guangzhou 71
Boston 70
Seattle 68
Munich 62
Redwood City 60
Hangzhou 55
Milan 54
Woodbridge 52
Helsinki 41
Warsaw 41
Hong Kong 38
Cambridge 35
Shanghai 35
Nanjing 33
Nuremberg 33
Pisa 32
Chennai 31
Los Angeles 31
Fremont 29
Grafing 29
Montréal 29
Palaiseau 25
Asti 23
Brussels 23
Seoul 23
Fortaleza 22
Tokyo 22
Buffalo 21
Dong Ket 20
Maasmechelen 20
Rome 20
Chengdu 19
Jakarta 19
Verona 17
Boardman 16
Hebei 16
Wuhan 16
Baltimore 15
Falls Church 15
Taipei 15
New York 14
San Diego 14
Evanston 13
Hasselt 13
Pittsburgh 13
Atlanta 12
Castellana Grotte 12
Copenhagen 12
Brisbane 11
Campinas 11
Chongqing 11
Guiyang 11
Hefei 11
Kunming 11
Berlin 10
Chicago 10
Norwalk 10
Sydney 10
Toronto 10
Bornem 9
Falkenstein 9
Kyoto 9
Lappeenranta 9
Ottawa 9
Paris 9
Rio de Janeiro 9
Heidelberg 8
Hyderabad 8
Jinan 8
London 8
Montreal 8
Naples 8
Phoenix 8
Shenzhen 8
Silver Spring 8
Tianjin 8
Trieste 8
Washington 8
Xian 8
Totale 7.705
Salva come PNG Salva come JPEG
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 723
Phosphoinositide 3-Kinase Gamma Inhibition Protects from Anthracycline Cardiotoxicity and Reduces Tumor Growth 695
Hemopexin Therapy Improves Cardiovascular Function by Preventing Heme-Induced Endothelial Toxicity in Mouse Models of Hemolytic Diseases 542
Hemopexin counteracts systolic dysfunction induced by heme-driven oxidative stress 524
Metabolic Alterations in a Slow-Paced Model of Pancreatic Cancer-Induced Wasting 343
Distinct Effects of Leukocyte and Cardiac Phosphoinositide 3-Kinase {gamma} Activity in Pressure Overload-Induced Cardiac Failure 315
Pulmonary-derived phosphoinositide 3-kinase gamma (PI3Kγ) contributes to ventilator-induced lung injury and edema. 260
Phosphoinositide 3-kinase γ protects against catecholamine-induced ventricular arrhythmia through protein kinase A-mediated regulation of distinct phosphodiesterases. 255
Contractile Function during Angiotensin-II Activation: Increased Nox2 Activity Modulates Cardiac Calcium Handling via Phospholamban Phosphorylation 252
Integrating Cardiac PIP(3) and cAMP Signaling through a PKA Anchoring Function of p110γ. 251
Identification of the macromolecular complex responsible for PI3Kgamma-dependent regulation of cAMP levels. 240
Anchoring proteins as regulators of signaling pathways. 239
Myocyte signalling in leucocyte recruitment to the heart. 239
Crossroads of PI3K and Rac pathways 235
Therapeutic applications of PI3K inhibitors in cardiovascular diseases. 232
Ablation of Calcineurin Aβ Reveals Hyperlipidemia and Signaling Cross-talks with Phosphodiesterases. 226
PI3K in cancer-stroma interactions: bad in seed and ugly in soil. 226
Lack of kinase-independent activity of PI3Kγ in locus coeruleus induces ADHD symptoms through increased CREB signaling 226
Specific PI3K Isoform Modulation in Heart Failure: Lessons from Transgenic Mice. 224
Dietary ω-3 fatty acids protect against vasculopathy in a transgenic mouse model of sickle cell disease 220
Disruption of ArhGAP15 results in hyperactive Rac1, affects the architecture and function of hippocampal inhibitory neurons and causes cognitive deficits 218
Taming the PI3K team to hold inflammation and cancer at bay 215
PI3K inhibition in inflammation:Toward tailored therapies for specific diseases 213
NADPH Oxidases in Heart Failure: Poachers or Gamekeepers? 212
Different inhibition of Gβγ-stimulated class IB phosphoinositide 3-kinase (PI3K) variants by a monoclonal antibody. Specific function of p101 as a Gβγ-dependent regulator of PI3Kγ enzymatic activity 208
Phosphoinositide 3-kinases in health and disease. 204
Hyper-activation of the Rho-GTPase Rac1 via disruption of ArhGAP15 results in reduced architectural and functional complexity 203
Hyperactivity of Rac1-GTPase pathway impairs neuritogenesis of cortical neurons by altering actin dynamics 196
Phosphoinositides and cardiovascular diseases. 195
Elastin degradation and ensuing inflammation as emerging keys to atherosclerosis. 194
Isoform Selective Phosphoinositide 3-Kinase gamma and delta Inhibitors and Their Therapeutic Potential 187
null 186
Metabolic Aspects of Anthracycline Cardiotoxicity 182
Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2α Scaffolding Function 163
Data demonstrating the anti-oxidant role of hemopexin in the heart 161
Molecular mechanism of action of Pelargonidin-3-O-glucoside, the main anthocyanin responsible for the anti-inflammatory effect of strawberry fruits 161
Antineoplastic drug-induced cardiotoxicity: A redox perspective 161
Therapeutic Targeting of PDEs and PI3K in Heart Failure with Preserved Ejection Fraction (HFpEF) 143
A PI3Kγ mimetic peptide triggers CFTR gating, bronchodilation, and reduced inflammation in obstructive airway diseases 142
Dysfunctional inflammation in cystic fibrosis airways: From mechanisms to novel therapeutic approaches 99
Liver-Specific siRNA-Mediated Stat3 or C3 Knockdown Improves the Outcome of Experimental Autoimmune Myocarditis 94
The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity 91
Rac signal adaptation controls neutrophil mobilization from the bone marrow 90
Pi3k signaling in chronic obstructive pulmonary disease: Mechanisms, targets, and therapy 89
Cardiac Overexpression of PDE4B Blunts β-Adrenergic Response and Maladaptive Remodeling in Heart Failure 89
Tregs restrain dendritic cell autophagy to ameliorate autoimmunity 81
Data demonstrating the role of peroxiredoxin 2 as important anti-oxidant system in lung homeostasis 80
PI(3,4)P2-mediated cytokinetic abscission prevents early senescence and cataract formation 80
New signal transduction paradigms in anthracycline-induced cardiotoxicity 79
Models of Heart Failure Based on the Cardiotoxicity of Anticancer Drugs 78
Toward standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC Working Group on Myocardial Function 78
Potential therapeutic applications of AKAP disrupting peptides 77
Cancer Risk in the Heart Failure Population: Epidemiology, Mechanisms, and Clinical Implications 77
Phosphoinositide 3-kinase: friend and foe in cardiovascular disease 76
PI3K and Calcium Signaling in Cardiovascular Disease 75
Mechanisms underlying the cross-talk between heart and cancer 74
PI3Ks in Diabetic Cardiomyopathy 72
A novel protective role for activating transcription factor 3 in the cardiac response to metabolic stress 69
Signaling pathways underlying anthracycline cardiotoxicity 68
Autophagy and cancer therapy cardiotoxicity: From molecular mechanisms to therapeutic opportunities 68
Peroxiredoxin-2 plays a pivotal role as multimodal cytoprotector in the early phase of pulmonary hypertension 67
Preventing and Treating Anthracycline Cardiotoxicity: New Insights 66
Cardiac dysfunction in cancer patients: Beyond direct cardiomyocyte damage of anticancer drugs: Novel cardio-oncology insights from the joint 2019 meeting of the ESC working groups of myocardial function and cellular biology of the heart 65
Therapeutic peptides for the treatment of cystic fibrosis: Challenges and perspectives 64
The human fetal and adult stem cell secretome can exert cardioprotective paracrine effects against cardiotoxicity and oxidative stress from cancer treatment 64
Inhaled Biologicals for the Treatment of Cystic Fibrosis 63
An integrated approach to cardioprotection in lymphomas 62
Cell signaling and regulation of CFTR expression in cystic fibrosis cells in the era of high efficiency modulator therapy 59
The Interplay Between Autophagy and Senescence in Anthracycline Cardiotoxicity 59
cAMP/PKA signaling compartmentalization in cardiomyocytes: Lessons from FRET-based biosensors 57
Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer? 57
Cell-specific roles of p110β in myocardial ischemia 56
New avenues in cardio-oncology 54
'Circulating' RNA-based therapies in Cardio-Oncology 52
Role of Protein Kinase A-Mediated Phosphorylation in CFTR Channel Activity Regulation 52
Combined inhibition of PI3Kβ and PI3Kγ reduces fat mass by enhancing α-MSH-dependent sympathetic drive. 51
Response by Vandecasteele et al to Letter Regarding Article, âCardiac Overexpression of PDE4B Blunts Î-Adrenergic Response and Maladaptive Remodeling in Heart Failureâ 51
Oxidative stress in anticancer therapies-related cardiac dysfunction 51
Understanding the common mechanisms of heart and skeletal muscle wasting in cancer cachexia 50
Duality of Nrf2 in iron-overload cardiomyopathy 47
Leukocyte and cardiac phosphoinositide 3-kinase γ activity in pressure overload-induced cardiac failure. 47
A non-catalytic function of PI3Kγ drives smooth muscle cell proliferation after arterial damage 47
Understanding the heart-brain axis response in COVID-19 patients: A suggestive perspective for therapeutic development 46
Inhibition of aquaporin-1 prevents myocardial remodeling by blocking the transmembrane transport of hydrogen peroxide 42
An intrinsic mechanism of metabolic tuning promotes cardiac resilience to stress 41
Roles of phosphatidyl inositol 3 kinase gamma (PI3Kγ) in respiratory diseases 38
Circulating hemopexin modulates anthracycline cardiac toxicity in patients and in mice 36
Neurotoxic Effect of Doxorubicin Treatment on Cardiac Sympathetic Neurons 35
Preclinical Models of Cancer Therapy-Associated Cardiovascular Toxicity: A Scientific Statement From the American Heart Association 34
It Takes Two to Tango! Protein–Protein Interactions behind cAMP-Mediated CFTR Regulation 32
In Humanized Sickle Cell Mice, Imatinib Protects Against Sickle Cell-Related Injury 32
Pi3k as mediator of apoptosis and contractile dysfunction in tgfβ1-stimulated cardiomyocytes 29
Extracellular vesicles derived from human livers stem cells counteract chronic kidney disease development and cardiac dysfunction in remnant kidney murine model: the possible involvement of proteases 28
MST1 mediates doxorubicin-induced cardiomyopathy by SIRT3 downregulation 28
Gene therapy with phosphodiesterases 2A and 4B ameliorates heart failure and arrhythmias by improving subcellular cAMP compartmentation 27
Emerging Roles of Phospholipase C Beta Isozymes as Potential Biomarkers in Cardiac Disorders 26
Illuminating cAMP Dynamics at Ryanodine Receptors in Arrhythmias 26
Young@Heart: empowering the next generation of cardiovascular researchers 25
p53 at the Intersection of Cardiac Fibroblast Proliferation and Activation: Answers and Questions 18
Editorial: Cardio-oncology and reverse cardio-oncology: the manifold interconnections between heart failure and cancer 15
Totale 13.494
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.682
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.682
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020720 0 0 0 0 0 0 0 0 0 242 232 246
2020/2021949 73 40 30 23 75 43 116 25 139 81 58 246
2021/20222.361 236 231 197 243 192 191 176 172 143 103 240 237
2022/20232.161 184 183 75 203 176 474 145 135 252 69 123 142
2023/20241.265 157 170 126 86 94 94 87 92 26 135 69 129
2024/20252.525 78 408 107 231 723 302 179 177 316 4 0 0
Totale 13.515